Inhibitory action of ethanolic extract of seeds of Moringa oleifera Lam. on systemic and local anaphylaxis

Journal of Immunotoxicology

Volumn 4, Issue 4, 2007, Pages 287-294

  Mahajan, Shailaja G ^a   Mehta, Anita A ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

Compound 48 80; Histamine; Immunoglobulin E; Moringa oleifera; Passive cutaneous anaphylaxis; Rat peritoneal mast cells

Indexed keywords

COMPOUND 48-80; IMMUNOGLOBULIN E ANTIBODY; MORINGA OLEIFERA EXTRACT;

ANAPHYLACTIC SHOCK; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HISTAMINE RELEASE; INSTITUTE FOR CANCER RESEARCH MOUSE; MAST CELL; MEDICINAL PLANT; MORINGA; NONHUMAN; PRIORITY JOURNAL; RAT; SEED; SKIN ANAPHYLAXIS; STATISTICAL SIGNIFICANCE; WISTAR RAT;

MORINGA OLEIFERA; MORINGACEAE; RATTUS;

EID: 36748998876     PISSN: 1547691X     EISSN: 1547691X     Source Type: Journal    
DOI: 10.1080/15476910701680137     Document Type: Article

References (72)

1. Anwar, F., and Bhanger, M. I. 2003. Analytical characterization of Moringa oleifera seed oil grown in temperate regions of Pakistan. J. Agric. Food Chem. 51:6558-6563.
2. Anwar, F., Ashraf, M., and Bhanger, M. I. 2005. Interprovenance variation in the composition of Moringa oleifera oil seeds from Pakistan. J. Am. Oil Chem. Soc. 82:45-51.
3. Bueb, J. L., Mousli, M. C., Bronner, C., Rouot, B., and Landry, Y. 1990. Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells. Mol. Pharmacol. 38:816-822.
4. Caceres, A., Cebreva, O., Morales, O., Miollined, P., and Mendia, P. 1991. Pharmacological properties of M. oleifera 1. Preliminary screening for antimicrobial activity. J. Ethnopharmacol. 33:213-216.
5. Caceres, A., Saravia, A., Rizzo, S., Zabala, L., De-Leon, E., and Nave, F. 1992. Pharmacological properties of M. oleifera 2. Screening for anti-spasmodic, anti-inflammatory and diuretic activity. J. Ethnopharmacol. 36:233-237.
6. Chopra, R. N., Chopra, I. C., Handa, K., and Kapur, D. (Eds.). 1938. Chopra's Indigenous Drugs of India. Calcutta: Dhur & Sons, Ltd.
7. Chuang, P. H., Lee, C. W., Chou, J. Y., Murugan, M., Shieh, B. J., and Chen, H. M. 2007. Anti-fungal activity of crude extracts and essential oil of Moringa oleifera Lam. Bioresource Technol. 98:232-236.
8. Dahot, M. U., and Memon, A. R. 1985. Nutritive significance of oil extracted from Moringa oleifera seeds. J. Pharm. Univ. Karachi. 3:75-80.
9. Das, B. R., Kurup, P. A., and Narasimha Rao, P. L. 1958. Antibiotic principle from Moringa Pterosperma Part IX. Inhibition of transaminase by isocyanates. Ind. J. Med. Res. 46:75-77.
10. Dayrit, F. M., Alcantara, A. D., and Villasenor, I. M. 1990. The antibiotic compound and its deactivation in aqueous solution. Phil. J .Sci. 119:23-26.
11. Ennis, M., Pearce, F. L., and Weston, P. M. 1980. Some studies on the release of histamine from mast cells stimulated with polysine. Br.J. Pharmacol. 70:329-334.
12. Faizi, S., Siddiqui, B. S., Saleem, R., Siddiqui, S., Aftab, K., and Gilani, A. H. 1995. Fully acetylated carbamate and hypotensive thiocarbamate glycosides from Moringa oleifera. Phytochemistry (Oxford). 38:957-963.
13. Guevara, A. P., Vargas, C., Sakurai, H., Fujiwara, Y., Hashimoto, K., Maoka, T., Kozuka, M., Ito, Y., Tokuda, H., and Nishino, H. 1999. An antitumor promoter from Moringa oleifera Lam. Mutat. Res. 440:181-188.
14. Gupta, P. P., Srimal, R. C. Srivastava, M., Singh, K. L., and Tondon, J. S. 1995. Anti-allergic activity of Arbortritosides from Nyctanthus arbortrists. Int. J. Pharmacog. 33:70-72.
15. Harish, M. S., Mallikarjun, N., and Badami, S. 2001. Antihistaminic and mast cell-stabilizing activity of Striga orobanchioides. J. Ethnopharmacol. 76:197-200.
16. Hong, S. H., Jeong, H. J., and Kim, H. M. 2003. Inhibitory effects of Xanthii fructus extract on mast cell-mediated allergic reaction in murine model. J. Ethnopharmacol. 88:229-234.
17. Hossen, M. A., Inoue, T., Shinmel, Y., Minami, K., Fujil, Y., and Chiaki, K. 2006. Caffeic acid inhibits Compound 48/80-induced allergic symptoms in mice. Biol. Pharm. Bull. 29:64-66.
18. Inagaki, N., Miura, T., Daikoku, M., Nagai, H., and Koda, A. 1989. Inhibitory effects of β-adrenergic stimulants on increased vascular permeability caused by passive cutaneous anaphylaxis, allergic mediators, and mediator releasers in rats. Pharmacology 39:19-27.
19. Inagaki, N., Miura, T., Ohira, K., Nagai, H., Xu, Q., and Koda, A. 1990. Effect of CV-3988, a specific antagonist against platelet activation factor, on homologous passive cutaneous anaphylaxis in the mouse ear. J. Pharmacobiodynam. 13:272-277.
20. Katayama, S., Shionoya, H., and Ohtake, S. 1978. A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous anaphylaxis in guinea pigs and rats. Microbiol. Immunol. 22:89-101.
21. Kemp, S. F., and Lockey, R. F. 2002. Anaphylaxis: A review of causes and mechanisms. J . Allergy Clin. Immunol. 110:341-348.
22. Kim, H. M., and Lee, Y. M. 1999. Role of TGF-β1 on the IgE-dependent anaphylaxis reaction. J. Immunol. 162:4960-4965.
23. Kim, H. M., Lee, E. H., Cho, H. H., and Moon, Y. H. 1998a. Inhibitory effect of mast cell-mediated immediate-type allergic reactions in rats by spirulina. Biochem. Pharmacol. 55:1071-1076.
24. Kim, H. M., Lee, E. H., Hong, S. H., Song, H. J., Shin, M. K., Kim, S. H., and Shin, T. Y. 1998b. Effect of Syzygium aromaticum extract on immediate hypersensitivity in rats. J. Ethnopharmacol. 60:125-131.
25. Kim, H. M., Lee, E. H., Kim, C. Y., Chung, J. G., Kim, S. H., Lim, J. P., and Shin, T. Y. 1997. Anti-anaphylactic properties of eugenol. Pharmacol. Res. 36:475-480.
26. Kim, M. S., Na, H. J., Han, S. W., Jin, J. S., Song, U. Y., Lee, E. J., Song, B. K, Hong, S. H., and Kim, H. M. 2003. Forsythia fructus inhibits the mast-cell-mediated allergic inflammatory reactions. Inflammation 27:129-135.
27. Kim, S. H., Choi, C. H., Kim, S. Y., Eun, J. S., and Shin, T. Y. 2005. Anti-allergic effects of Artemisia iwayomogi on mast cell-mediated allergy model. Exp. Biol. Med. 230:82-88.
28. Kim, S. H., Choi, Y. K., Jeong, H. J., Kang, H. U., Moon, G., Shin, T. Y., and Kim, H. M. 2000. Suppression of immunoglobulin E-mediated anaphylactic reaction by Alpinia oxyphylla in rats. Immunopharmacol. Immunotoxicol. 22:267-277.
29. Kirtikar, K. R., and Basu, B. D. 1975. Indian Medicinal Plants, 2nd Edition, Vol. 1, eds. D. Dun, B. Singh, and M. P. Singh, Eds.), pp. 676-683. New Cannaught Place, Dehradun: M/s Bishen Singh Mahendra Pal Singh.
30. Laandrault, N., Pouchert, P., Ravel, P., Gase, F., Cros, G., and Teissedro, P. L. 2001. Antioxidant activities phenolic level of French wines from different varieties and vintages. J . Agric. Food Chem. 49:3341-3343.
31. Lako, J., Trenerry V. C., Wahlqvist, M., Wattanapenpaiboon, N., and Sotheeswaran, S. 2007. Phytochemical flavonols, carotenoids and the antioxidant properties of a wide selection of Fijian fruit, vegetables and other readily available foods. Food Chem. 101:1727-1741.
32. Lee, Y. M., Kim, C. Y., Kim, Y. C., and Kim, H. M. 1997. Effects of Poncirus trifoliata on type I hypersensitivity reaction. Am. J. Chin. Med. 25:51-56.
33. Mahajan, S. G., Mali, R. G., and Mehta, A. A. 2006. Anti-anaphylactic and anti-inflammatory activity of hydroalcoholic extract of leaves of Moringa oleifera. Planta Indica 2:9-13.
34. Mahajan, S. G., Mali, R. G., and Mehta, A. A. 2007. Effect of Moringa oleifera Lam. seed extract on toluene diisocyanate-induced immune-medicated inflammatory responses in rats. J. Immunotoxicol. 4:143-157.
35. Mahajan, S. G., Mali, R. G., and Mehta, A. A. 2007. Protective effect of ethanolic Extract of seeds of Moringa oleifera Lam. against inflammation associated with development of arthritis in rats. J. Immunotoxicol. 4:39-47.
36. Makkar, H. P., and Becker, K. 1996. Nutritional value and anti-nutritional components of whole and extracted Moringa oleifera leaves. Anim. Feed Sci. Technol. 63:211-228.
37. Makkar, H. P., and Becker, K. 1997. Nutrients and antiquality factors in different morphological parts of the Moringa oleifera tree. J. Agric. Sci. 128:311-322.
38. Marles, R. J., and Farnsworth, N. R. 1995. Anti-diabetic plants and their active constituents. Phytomedicine 2:137-189.
39. Memon, G. M., and Khatri, L. M. 1987. Isolation and spectroscopic studies of mono-palmitic, di-oleic triglyceride from seeds of Moringa oleifera Lam. Pak. J. Sci. Ind. Res. 30:393-395.
40. Metcalfe, D. D., Kaliner M., and Donlon, M. A. 1981. The mast cell. Crit. Rev. Immunol. 3:23-74.
41. Metzger, H., Alcaraz, G., Gogman, R., Kinet, J. P., Pribluda, V., and Quarto, R. 1986. The receptor with high affinity for immunoglobulin E. Ann. Rev. Immunol. 4:419-470.
42. Miescher, S. M., and Vogel, M. 2002. Molecular aspects of allergy. Mol. Aspects Med. 23:413-462.
43. Moon, P. D., Na, H. J., and Kim, H. M. 2003. Action of enzyme food, Green Life Enzyme, on systemic and local anaphylaxis. Orient. Pharm. Exp. Med. 3:46-50.
44. Mousli, M. C., Bronner, C., Bockaert, J., Rouot, B., and Landry, Y. 1990a. Interaction of substance P, compound 48/80, and mastoparan with αsubunit C-terminal of G protein. Immunol. Lett. 25:355-358.
45. Mousli, M. C., Bronner, C., Landry, Y., Bockaert, J., and Rouot, B. 1990b. Direct activation of GTP-binding regulatory proteins (G proteins) by Substance P and Compound 48/80. FEBS Lett. 259:260-262.
46. Mughal, M. H., Ali, G., Srivastava, P. S., and Iqbal, M. 1999. Improvement of drumstick (Moringa pterygosperms Gaertn.) a unique source of food and medicine through tissue culture. Hamdard Med. 42:37-42.
47. Na, H. J., Jeong, H. J., Bae, H., Kim, Y. B., Park, S. T., Yun, Y. G., and Kim, H. M. 2002. Tongkyutang inhibits mast cell-dependent allergic reactions and inflammatory cytokine secretion. Clin. Chim. Acta 319:35-41.
48. Njoku, O. U., and Adikwu, M. U. 1997. Investigation on some physicochemical antioxidant and toxicological properties of Moringa oleifera seed oil. Acta. Pharma. Zagr. 47:287-290.
49. Okpo, S. O., and Adeyemi, O. O. 2002. The antianaphylactic effects of Crinum glaucum aqueous extract. J. Ethnopharmacol. 81:187-190.
50. Paech, D., and Tracey, M. V. (Eds.) Modern Methods of Plant Analysis, Vol. IV, Springer- Verlag: Berlin, 1955, pp. 373-374.
51. Petersen, L. J., Mosbech, H., and Skov, P. 1996. Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: Characterization of factors influencing histamine release ability. J. Allergy Clin. Immunol. 97:672-679.
52. Prakash, A. O., Pathak, S., Shukla, S., and Mathur, R. 1988. Pre- and post-implantation changes in the uterus of rats: Response to Moringa oleifera Lam. extract. Ancient Sci. Life 8:49-54.
53. Rafferty, P., and Holgate, S. T. 1989. Histamine and its antagonists in asthma. J. Allergy Clin. Immunol. 84:144-151.
54. Rao, C. V., Ojha, S. K., and Mehrotra, S. 2003. Analgesic effect of Moringa oleifera leaf extract on rats. In: Proceedings of the Second World Congress on Biotechnological Developments of Herbal Medicine, Lucknow, India, p. 42.
55. Rimmers, S. J., and Church, M. K. 1990. The pharmacology and mechanisms of action of histamine H1-antagonist. Clin. Exp. Allergy 20:3-17.
56. Royer, B., Varadaradjalou, S., Saas, P., Gabiot, A. C., Kantelip, B., Feger, F., Guillosson, J. J., Kantelip, J. P., and Arock, M. 2001. Autocrine regulation of cord blood derived human mast cell activation by IL-10. J. Allergy Clin. Immunol. 108:80-86.
57. Ruckmani, K., Kavimani, S., Anandan, R., and Jaykar, B. 1998. Effect of Moringa oleifera Lam. on paracetamol induced hepatotoxicity. Ind. J. Pharm. Sci. 60:33-35.
58. Saito, H., and Nomura, Y. 1989. Screening methods for drug evaluation-3. In: Pharmaceutical Research and Development,eds. L.Suzuki, H. Tanaka, H. Yajima, H. Fukuda, H. Sezaki, K. Koga, M. Hirobe, and T. Nakajime, p. 22. Tokyo: Hirokawa.
59. Shin, T. Y., Kim, S. H., Lim, J. P., Suh, E. S., Jeong, H. J., Kim, B. D., Park, E. J., Hwang, W. J., Rye D. G., Baek, S. H., An, N. H., and Kim, H. M. 2000. Effect of Vitex rotundifolia on immediate-type allergic reaction. J. Ethnopharmacol. 72:443-450.
60. Shin, T. Y., Kim, S. H., Suk, K., Ha, J. H., Kim, I. K., Lee, M. G., Jun, C. D., Kim, S. Y., Lim, J. P., Eun, J. S., Shin, H. Y., and Kim, H. M. 2005. Anti-allergic effects of Lycopus lucidus on mast cell-mediated allergy model. Toxicol. Appl. Pharmacol. 209:255-262.
61. Shore, P. A., Burkhalter, A., and Cohn, V. H. 1959. A method for fluorometric assay of histamine in tissues. J. Pharmacol. Exp. Ther. 127:182-186.
62. Singh, R., Nath, A., Gupta, P. P., Shukla, M., Khare, S. K., and Kundu, B. 1998. Anti-allergic/anti-asthmatic activity of oligopeptide related to IgE. Pharmacol. Res. 37:353-356.
63. Stassen, M., Muller, C., Arnold, M., Hultner, L., Klein-Hessling, S., Neudorfl, C., Reineke, T., Serfling, E., and Schmitt, E. 2001. IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-κB is decisively involved in the expression of IL-9. J. Immunol. 166:4391-4398.
64. Udupa, S. L., Udupa, A. L., and Kulkarni, D. R. 1994. Studies on the anti-inflammatory and wound healing properties of Moringa oleifera and Aegle marmelos. Fitoterapia. 65:119-23.
65. Varier, V. P. 1997. Indian Medicinal Plants Compendium of 500 species. Vol. 4, eds. P. K. Warrier, V. P. Nambiar, and C. Ramankutty, pp. 58-62. Madras: Orient Longman Ltd.
66. Villasenor, I. M. 1994. Bioactive metabolites from Moringa oleifera Lam. Kimika 110:47-52.
67. Villasenor, I. M., Dayrit, F., and Lim-Sylianco, C. Y. 1990. Studies on M. oleifera seeds, Part II. Thermal degradation of roasted seeds. Phil. J. Sci. 119:33-39.
68. Villasenor, I. M., Lim-Sylianco, C. Y., and Dayrit, F. 1989. Mutagens from roasted seeds of Moringa oleifera. Mutat.Res. 224:209-212.
69. Wasserman, S. I., and Marquardt, D. L. (Eds.) 1988. Anaphylaxis in Allergy: Principles and Practice, 3rd Edition. St. Louis: Mosby.
70. 125I-Fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin: Demonstration of role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J. Immunol. 139:2605-2614.
71. Yun, Y., Han, S., Park, E., Yim, D., Lee, S., Lee, C. K., Cho, K., and Kim, K. 2003. Immunomodulatory activity of betulinic acid by producing proinflmmatory cytokines and activation of macrophages. Arch. Pharmacol Res. 26:1087-1095.
72. Yurt, R. W., Leid, R. W., and Austen, K. F. 1977. Native heparin from rat peritoneal mast cells. J. Biol. Chem. 252:518-521.